-
-
-
Ki-Suck Jung
President, APSR 2022
Local Congress Committee
Professor, Hallym University College of Medicine -
Jae Jeong Shim
Secretary General, APSR 2022
Local Congress Committee
Professor, Korea University College of Medicine -
Jang-Won Sohn
Vice Secretary General, APSR 2022
Local Congress Committee
Professor, Hanyang University College of Medicine -
Kwang Ha Yoo
Vice Secretary General, APSR 2022
Local Congress Committee
Professor, Konkuk University School of Medicine -
Chin Kook Rhee
Vice Secretary General, APSR 2022
Local Congress Committee
Professor, The Catholic University of Korea College of Medicine
-
Speaker's Highlight
-
-
Don Sin
University of British Columbia, St. Paul Hospital (Canada)
Kenneth R. Chapman
Toronto General Hospital Research Institute (Canada)
-
Parameswaran Nair
McMaster University (Canada)
Carolyn Calfee
UCSF (U.S.A.)
-
Gregory P. Downey
University of Colorado School of Medicine (U.S.A.)
David A. Schwartz
University of Colorado School of Medicine (U.S.A.)
-
Neil Schluger
Tuberculosis Control Branch, California Department of Public Health (U.S.A.)
Nick Kim
Critical Care & Sleep Medicine, University of California San Diego (U.S.A.)
-
Nicola Hananiah
Baylor College of Medicine (U.S.A.)
Jae-Joon Yim
Seoul National University College of Medicine (Republic of Korea)
-
Koichiro Asano
Tokai University School of Medicine (Japan)
Diahn-Warng Perng
Taipei Veterans General Hospital (Taiwan)
-
Konstantinos Kostikas
University of Ioannina (Greece)
Karin Klooster
University Medical Center Groningen (Kingdom of the Netherlands)
-
News
Pulmonary toxicity from immune checkpoint inhibitors: a clinical overviewImmune checkpoint inhibitors have reshaped cancer treatment in Australia and overseas, with agents such as nivolumab, pembrolizumab, atezolizumab and…From Tiotropium to Dual Bronchodilation in COPD ManagementFor decades, long-acting muscarinic antagonists such as tiotropium formed the backbone of maintenance therapy for chronic obstructive pulmonary disease.…Computational Modeling of Airflow in Asthmatic AirwaysAsthma remains one of the most common chronic respiratory conditions in Australia, where more than two million adults and children live with the diagnosis.…Therapeutic drug monitoring for anti-tuberculosis agentsTherapeutic drug monitoring (TDM) involves measuring the concentration of medicines in patient serum or plasma to tailor dosing to the individual. In…Exercise-Induced Laryngeal Obstruction in Young AthletesFor a teenager gasping at the finish line of a Saturday arvo cross-country run, the immediate assumption is often asthma. Many clinicians in Australia default…New Developments in the Diagnosis of Pulmonary Vascular DiseaseMedicine rarely advances in straight lines, and the pathway to identifying disease of the small arteries and veins supplying the lungs has been a textbook…Microbiome Shifts Driving Bronchiectasis ProgressionThe respiratory microbiome has emerged as one of the most fascinating frontiers in chronic lung disease research, and bronchiectasis sits squarely at the…Living with post-tuberculosis lung disease: sequelae and managementTuberculosis remains one of the most consequential infectious diseases in human history, and although Australia records far fewer active cases than many…Spotting COPD Flare-Ups Early with Remote MonitoringFor people living with chronic obstructive pulmonary disease, a sudden worsening of breathlessness, cough or sputum can quickly spiral into a hospital…Innate lymphoid cells and their emerging role in asthma pathogenesisAsthma affects roughly one in nine Australians, placing the country among the higher-prevalence regions worldwide. In major centres such as Sydney, Melbourne,…
Richard Russell
Nuffield Department of Clinical Medicine, University of Oxford (United Kingdom)
-
Mona Bafadhel
King’s College London (United Kingdom)
David Jackson
Guy’s and St Thomas’ Hospital, King’s College London (United Kingdom)
-
James Chalmers
University of Dundee (United Kingdom)
David Price
University of Aberdeen (United Kingdom)
-
-
Hosted
by
-
-
Sponsored
by
